 |
Some patients with anemia of chronic disease have impaired function and quality of life, and the disorder contributes to poor outcomes in patients with chronic kidney disease, chronic heart failure, and malignancies. Here is a guide for deciding which patients would benefit from treatment—and which therapeutic options to choose. Nov 1, 2006 By:
A. Kesh Hebbar, MD, MARIA V. GIBSON, MD, PhD

|
Some patients with anemia of chronic disease have impaired function and quality of life, and the disorder contributes to poor outcomes in patients with chronic kidney disease, chronic heart failure, and malignancies. Here is a guide for deciding which patients would benefit from treatment—and which therapeutic options to choose.  Cerebral aneurysms can quickly become a life-threatening medical emergency if they rupture. A heightened awareness of the possibility that cerebral aneurysms may have formed can help ensure that your patients receive the specialized care they need in a timely manner. Nov 1, 2006 By:
Randall T. Higashida, MD, Kiwon Lee, MD, Christopher S. Ogilvy, MD

|
Cerebral aneurysms can quickly become a life-threatening medical emergency if they rupture. A heightened awareness of the possibility that cerebral aneurysms may have formed can help ensure that your patients receive the specialized care they need in a timely manner.  A high percentage of surgical patients are at risk for venous thromboembolism. Effective prophylaxis exists, but many patients remain vulnerable to this potentially deadly complication of surgery. Are your patients adequately protected? Oct 1, 2006 By:
JAMES A. FINK, MD, MS, Peter J. Kaboli, MD, MS
|
A high percentage of surgical patients are at risk for venous thromboembolism. Effective prophylaxis exists, but many patients remain vulnerable to this potentially deadly complication of surgery. Are your patients adequately protected?  Now that the American Heart Association has issued its new guidelines, we need to carefully consider each woman's risk for coronary heart disease (CHD). Educating women today about their lifetime risk for CHD and working with every patient to implement the guidelines for CHD risk prevention may have a significant impact on women's health for the future. Dec 15, 2007 By:
Jessica Salt, MD, Matthew DeCaro, MD
|
Now that the American Heart Association has issued its new guidelines, we need to carefully consider each woman's risk for coronary heart disease (CHD). Educating women today about their lifetime risk for CHD and working with every patient to implement the guidelines for CHD risk prevention may have a significant impact on women's health for the future.  Job strain after first MI linked to future heart problems; Adding single insulin to oral drugs fails most diabetics; Screening not equally useful in all chest-pain patients; HDL predicts risk of major cardiovascular events  Are women with polycystic ovary syndrome at increased risk of cardiovascular disease and, if so, what preventive measures need to be addressed? Dec 15, 2007 By:
MARIA V. GIBSON, MD, PhD
|
Are women with polycystic ovary syndrome at increased risk of cardiovascular disease and, if so, what preventive measures need to be addressed?  Dec 15, 2007 By:
Judith Asch-Goodkin, Deborah Kaplan
|
CABG or PCI? It's a dead heat; Diabetes regimens: For some, the treatment is worse than the disease; News from the FDA  The use of bridge therapy in patients on chronic oral anticoagulation who are undergoing surgery or other invasive procedures needs to be evaluated case by case. Though full-dose unfractionated heparin is the current standard, low-molecular-weight heparin appears to be as safe and effective—and much simpler and less expensive to use. Oct 17, 2007 By:
Mirza E. Perez, PharmD, MARK G. GRAHAM, MD
|
The use of bridge therapy in patients on chronic oral anticoagulation who are undergoing surgery or other invasive procedures needs to be evaluated case by case. Though full-dose unfractionated heparin is the current standard, low-molecular-weight heparin appears to be as safe and effective—and much simpler and less expensive to use.  Cardiac troponin levels can have important prognostic implications and often guide the course of treatment in patients with acute coronary syndromes, MI, and other illnesses. Learn how to best use these important tests in clinical practice. Oct 16, 2007 By:
Matthew DeCaro, MD
|
Cardiac troponin levels can have important prognostic implications and often guide the course of treatment in patients with acute coronary syndromes, MI, and other illnesses. Learn how to best use these important tests in clinical practice. 
 |
|